学术探索
学术期刊
新闻热点
数据分析
智能评审

SYSTEMIC TREATMENT OF KAPOSIS-SARCOMA - CURRENT STATUS AND FUTURE-DIRECTIONS

被引：32
作者：
LILENBAUM, RC
RATNER, L
机构：
[1] WASHINGTON UNIV,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110
来源：
AIDS | 1994年 / 8卷 / 02期
关键词：
HIV; TAT; CYTOKINES; ANGIOGENESIS; CHEMOTHERAPY; INTERFERON;
D O I：
10.1097/00002030-199402000-00001
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：141 / 151
页数：11
相关论文
共 97 条
  • [91] VINBLASTINE THERAPY FOR KAPOSIS SARCOMA IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME
    VOLBERDING, PA
    ABRAMS, DI
    CONANT, M
    KASLOW, K
    VRANIZAN, K
    ZIEGLER, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 335 - 338
  • [92] VONROENN J, 1993, P AN M AM SOC CLIN, V12, P51
  • [93] WADLER S, 1992, CANCER S, V70, pS949
  • [94] TUMOR-GROWTH DEPENDENT ON KAPOSIS SARCOMA-DERIVED FIBROBLAST GROWTH-FACTOR INHIBITED BY PENTOSAN POLYSULFATE
    WELLSTEIN, A
    ZUGMAIER, G
    CALIFANO, JA
    KERN, F
    PAIK, SM
    LIPPMAN, ME
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10): : 716 - 720
  • [95] HUMAN ALPHA-INTERFERON AND INTERFERON-BETA BUT NOT GAMMA-INTERFERON SUPPRESS THE INVITRO REPLICATION OF LAV, HTLV-III, AND ARV-2
    YAMAMOTO, JK
    BARRESINOUSSI, F
    BOLTON, V
    PEDERSEN, NC
    GARDNER, MB
    [J]. JOURNAL OF INTERFERON RESEARCH, 1986, 6 (02): : 143 - 152
  • [96] ZANIBONI A, 1990, MED ONCOL TUMOR PHAR, V7, P287
  • [97] ZIEGLER JL, 1984, LANCET, V2, P641
12345678910